Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Type A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03417869
What this trial is testing

QuickVue Influenza A + B Test Field Study

Who this might be right for
Influenza A, Influenza B
Quidel Corporation 1,381
Not applicableWithdrawnNCT00640302
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07503405
What this trial is testing

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Who this might be right for
Influenza
Traws Pharma, Inc. 165
Large-scale testing (Phase 3)Study completedNCT02572817
What this trial is testing

Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A

Who this might be right for
Influenza A Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 138
Testing effectiveness (Phase 2)UnknownNCT01719874
What this trial is testing

Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza

Who this might be right for
Influenza
Theraclone Sciences, Inc. 64
Large-scale testing (Phase 3)Study completedNCT06385821
What this trial is testing

Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Who this might be right for
InfluenzaInfluenza AInfluenza, Human+8 more
NPO Petrovax 824
Early research (Phase 1)Study completedNCT00457509
What this trial is testing

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic InfluenzaInfluenza A Virus InfectionOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 251
Testing effectiveness (Phase 2)Study completedNCT03497845
What this trial is testing

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza A Virus, H5N1 Subtype
Biomedical Advanced Research and Development Authority 720
Testing effectiveness (Phase 2)Study completedNCT02342249
What this trial is testing

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

Who this might be right for
Influenza A
Janssen Research & Development, LLC 292
Testing effectiveness (Phase 2)Study completedNCT00992017
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 130
Testing effectiveness (Phase 2)Study completedNCT01841918
What this trial is testing

Safety and Immunogenicity of Live Attenuated Influenza H5N2

Who this might be right for
Influenza Due to Influenza A Virus Subtype H5N2
Mahidol University 150
Early research (Phase 1)Study completedNCT01317758
What this trial is testing

H5N1 Mix and Match With AS03

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 245
Post-approval studies (Phase 4)Study completedNCT06567860
What this trial is testing

Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

Who this might be right for
Influenza A
La Jolla Institute for Immunology 23
Not applicableStudy completedNCT00979381
What this trial is testing

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Who this might be right for
Renal Cell CarcinomaGIST
Radboud University Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT02921997
What this trial is testing

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Who this might be right for
Avian InfluenzaH1N1 InfluenzaInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00900588
What this trial is testing

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd
Not applicableWithdrawnNCT00417560
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses

Who this might be right for
Influenza
Centers for Disease Control and Prevention
Not applicableLooking for participantsNCT06620185
What this trial is testing

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Who this might be right for
Influenza
Imperial College London 36
Not applicableWithdrawnNCT06163677
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza.

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00963157
What this trial is testing

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 789
Next Page